06.10.2010Pathwork Diagnostics Completes $30M Series C Round

Capital to Accelerate Commercialization and Market Share for FDA-cleared Tissue of Origin Test

Press Release
06.10.2010Amsterdam Molecular Therapeutics successfully raised €14.3m through an Equity Issue

Amsterdam Molecular Therapeutics (AMT) Holding N.V. (Euronext: AMT) announces today that it has successfully raised € 14.3 m in gross proceeds through a private placement of new shares with institutional investors

Press Release
05.10.2010SEP, the Pan-European Specialty Urology Company, acquires Mitem

Press Release
04.10.2010Avila Initiates Phase 1 Clinical Study of AVL-292, a Targeted Covalent Drug and Novel Potential Treatment for B Cell Cancers and Autoimmune Diseases

Press Release
03.08.2010Algeta concludes agreements for the manufacture and supply of Alpharadin for future commercial sale

Press Release
02.08.2010Pathwork Diagnostics Partners with Leading Pharmaceutical Company to Discover Molecular Diagnostics for Cancer

Press Release
19.07.2010MediGene sells full European rights for Eligard to Astellas for EUR 25 million and ongoing royalties

Press Release
24.06.2010MediGene reports additional phase II results of EndoTAGTM-1 for the treatment of triple receptor-negative breast cancer

Press Release
15.06.2010Micromet's Blinatumomab Induces Durable Remissions in Patients with Relapsed Non-Hodgkin's Lymphoma

Press Release
15.06.2010Amsterdam Molecular Therapeutics reports Positive New Clinical Data from Glybera Study

Press Release